{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:09Z","timestamp":1793382909284,"version":"4.5.0"},"reference-count":82,"publisher":"American Medical Association (AMA)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:sec id=\"ab-jrv230017-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Bipolar disorder affects approximately 8 million adults in the US and approximately 40 million individuals worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv230017-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Bipolar disorder is characterized by recurrent episodes of depression and mania or hypomania. Bipolar depressive episodes are similar to major depressive episodes. Manic and hypomanic episodes are characterized by a distinct change in mood and behavior during discrete time periods. The age of onset is usually between 15 and 25 years, and depression is the most frequent initial presentation. Approximately 75% of symptomatic time consists of depressive episodes or symptoms. Early diagnosis and treatment are associated with a more favorable prognosis. Diagnosis and optimal treatment are often delayed by a mean of approximately 9 years following an initial depressive episode. Long-term treatment consists of mood stabilizers, such as lithium, valproate, and lamotrigine. Antipsychotic agents, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine, are recommended, but some are associated with weight gain. Antidepressants are not recommended as monotherapy. More than 50% of patients with bipolar disorder are not adherent to treatment. Life expectancy is reduced by approximately 12 to 14 years in people with bipolar disorder, with a 1.6-fold to 2-fold increase in cardiovascular mortality occurring a mean of 17 years earlier compared with the general population. Prevalence rates of metabolic syndrome (37%), obesity (21%), cigarette smoking (45%), and type 2 diabetes (14%) are higher among people with bipolar disorder, contributing to the risk of early mortality. The annual suicide rate is approximately 0.9% among individuals with bipolar disorder, compared with 0.014%\u2009in the general population. Approximately 15% to 20% of people with bipolar disorder die by suicide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv230017-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Bipolar disorder affects approximately 8 million adults in the US. First-line therapy includes mood stabilizers, such as lithium, anticonvulsants, such as valproate and lamotrigine, and atypical antipsychotic drugs, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.18588","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:02:31Z","timestamp":1696935751000},"page":"1370","source":"Crossref","is-referenced-by-count":417,"title":["Diagnosis and Treatment of Bipolar Disorder"],"prefix":"10.1001","volume":"330","author":[{"given":"Andrew A.","family":"Nierenberg","sequence":"first","affiliation":[{"name":"Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Agustini","sequence":"additional","affiliation":[{"name":"Deakin University, IMPACT \u2013 the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"K\u00f6hler-Forsberg","sequence":"additional","affiliation":[{"name":"Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston"},{"name":"Department for Affective Disorder, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Psychosis Research Unit, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cusin","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Depression Clinical and Research Program, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Katz","sequence":"additional","affiliation":[{"name":"Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa G.","family":"Sylvia","sequence":"additional","affiliation":[{"name":"Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Peters","sequence":"additional","affiliation":[{"name":"Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[{"name":"Deakin University, IMPACT \u2013 the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia"},{"name":"Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"jrv230017r1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"jrv230017r2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2215-0366(23)00193-1","article-title":"Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries.","volume":"10","author":"Mcgrath","year":"2023"},{"issue":"2","key":"jrv230017r3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature.","volume":"37","author":"Clemente","year":"2015","journal-title":"Braz J Psychiatry"},{"issue":"267","key":"jrv230017r5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jad.2020.02.035","article-title":"Psychiatric comorbidities in bipolar disorders: an examination of the prevalence and chronology of onset according to sex and bipolar subtype.","volume":"267","author":"Loftus","year":"2020","journal-title":"J Affect Disord"},{"issue":"5","key":"jrv230017r6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1176\/appi.ajp.2017.17090972","article-title":"Early intervention in bipolar disorder.","volume":"175","author":"Vieta","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"5","key":"jrv230017r7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bdi.2017.19.issue-5","article-title":"Is a delay in the diagnosis of bipolar disorder inevitable?","volume":"19","author":"Fritz","year":"2017","journal-title":"Bipolar Disord"},{"issue":"1","key":"jrv230017r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.psy.0000151489.36347.18","article-title":"Psychiatric and medical comorbidities of bipolar disorder.","volume":"67","author":"Krishnan","year":"2005","journal-title":"Psychosom Med"},{"issue":"3","key":"jrv230017r10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/acps.2018.138.issue-3","article-title":"Characteristics of depressive and bipolar disorder patients with mixed features.","volume":"138","author":"Tondo","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"jrv230017r11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.genhosppsych.2015.12.005","article-title":"Factors related to suicidal behavior in patients with bipolar disorder: the effect of mixed features on suicidality.","volume":"39","author":"Seo","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"jrv230017r12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1192\/bjp.2022.19","article-title":"Life expectancy and years of potential life lost in bipolar disorder: systematic review and meta-analysis.","volume":"221","author":"Chan","year":"2022","journal-title":"Br J Psychiatry"},{"issue":"2","key":"jrv230017r13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11920-020-1130-0","article-title":"Bipolar disorder and suicide: a review.","volume":"22","author":"Miller","year":"2020","journal-title":"Curr Psychiatry Rep"},{"key":"jrv230017r14","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796019000593","article-title":"Prevalence of suicide attempts in bipolar disorder: a systematic review and meta-analysis of observational studies.","volume":"29","author":"Dong","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"242","key":"jrv230017r15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jad.2018.08.054","article-title":"Association between completed suicide and bipolar disorder: a systematic review of the literature.","volume":"242","author":"Plans","year":"2019","journal-title":"J Affect Disord"},{"issue":"6","key":"jrv230017r16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/acps.12408","article-title":"A systematic review and meta-analysis of premature mortality in bipolar affective disorder.","volume":"131","author":"Hayes","year":"2015","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"jrv230017r17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"jrv230017r18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/bdi.2015.17.issue-6","article-title":"A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults.","volume":"17","author":"Jackson","year":"2015","journal-title":"Bipolar Disord"},{"issue":"6","key":"jrv230017r19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7247","article-title":"Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness: a randomized clinical trial.","volume":"3","author":"Daumit","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"jrv230017r20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bdi.v21.7","article-title":"Beyond evidence-based treatment of bipolar disorder: Rational pragmatic approaches to management.","volume":"21","author":"Post","year":"2019","journal-title":"Bipolar Disord"},{"issue":"8","key":"jrv230017r21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/bdi.v22.8","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary.","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disord"},{"issue":"2","key":"jrv230017r22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","article-title":"Pharmacological treatment of adult bipolar disorder.","volume":"24","author":"Baldessarini","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"9","key":"jrv230017r23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S2215-0366(23)00199-2","article-title":"Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.","volume":"10","author":"Yildiz","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"jrv230017r24","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/s41380-021-01334-4","article-title":"Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.","volume":"27","author":"Kishi","year":"2022","journal-title":"Mol Psychiatry"},{"key":"jrv230017r25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.euroneuro.2021.08.264","article-title":"Preventing new episodes of bipolar disorder in adults: systematic review and meta-analysis of randomized controlled trials.","volume":"54","author":"Nestsiarovich","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"jrv230017r26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/bdi.2009.11.issue-6","article-title":"The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.","volume":"11","author":"Ng","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"jrv230017r27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.2018.20.issue-2","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"issue":"2","key":"jrv230017r29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ijnp\/pyw100","article-title":"The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 2: review, grading of the evidence, and a precise algorithm.","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"jrv230017r30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bdi.v22.8","article-title":"Pharmacological management of bipolar disorder: Japanese expert consensus.","volume":"22","author":"Sakurai","year":"2020","journal-title":"Bipolar Disord"},{"issue":"6","key":"jrv230017r31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/NMD.0000000000001151","article-title":"Illness insight and medication adherence among patients with bipolar disorder.","volume":"208","author":"Guti\u00e9rrez-Rojas","year":"2020","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"jrv230017r32","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2220","article-title":"Predicting involuntary hospitalization in psychiatry: a machine learning investigation.","volume":"64","author":"Silva","year":"2021","journal-title":"Eur Psychiatry"},{"issue":"3","key":"jrv230017r33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","article-title":"Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis.","volume":"19","author":"Barton","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"jrv230017r34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1017\/S1092852916000523","article-title":"Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.","volume":"21","author":"Solmi","year":"2016","journal-title":"CNS Spectr"},{"issue":"1","key":"jrv230017r35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.","volume":"194","author":"Geddes","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"2","key":"jrv230017r36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.","volume":"70","author":"van der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"jrv230017r37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S2215-0366(15)00450-2","article-title":"Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 \u00d7 2 factorial randomised trial.","volume":"3","author":"Geddes","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"jrv230017r38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: an enduring controversy.","volume":"6","author":"Gitlin","year":"2018","journal-title":"Int J Bipolar Disord"},{"issue":"11","key":"jrv230017r39","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"February","key":"jrv230017r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114468","article-title":"Adjunctive antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.","volume":"311","author":"Hu","year":"2022","journal-title":"Psychiatry Res"},{"issue":"12","key":"jrv230017r41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S2215-0366(16)30264-4","article-title":"Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.","volume":"3","author":"McGirr","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"jrv230017r42","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa2300184","article-title":"Duration of adjunctive antidepressant maintenance in bipolar I depression.","volume":"389","author":"Yatham","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv230017r43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/acps.2019.139.issue-3","article-title":"ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression.","volume":"139","author":"Bahji","year":"2019","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"jrv230017r44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/acps.v140.3","article-title":"Electroconvulsive therapy in bipolar depression: effectiveness and prognostic factors.","volume":"140","author":"Popiolek","year":"2019","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"jrv230017r45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.psc.2016.04.004","article-title":"Adverse effects of electroconvulsive therapy.","volume":"39","author":"Andrade","year":"2016","journal-title":"Psychiatr Clin North Am"},{"issue":"6","key":"jrv230017r46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology.","volume":"30","author":"Goodwin","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"5","key":"jrv230017r47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"jrv230017r48","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/npp.2017.238","article-title":"The new news about lithium: an underutilized treatment in the United States.","volume":"43","author":"Post","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"9817","key":"jrv230017r49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis.","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"issue":"9992","key":"jrv230017r50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(14)61842-0","article-title":"Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data.","volume":"386","author":"Shine","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"jrv230017r51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40345-017-0096-2","article-title":"Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters.","volume":"5","author":"Tondo","year":"2017","journal-title":"Int J Bipolar Disord"},{"issue":"1","key":"jrv230017r52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40345-020-00204-2","article-title":"Chronic kidney disease in lithium-treated patients, incidence and rate of decline.","volume":"9","author":"Van Alphen","year":"2021","journal-title":"Int J Bipolar Disord"},{"key":"jrv230017r53","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jad.2017.03.052","article-title":"The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines.","volume":"217","author":"Malhi","year":"2017","journal-title":"J Affect Disord"},{"issue":"3","key":"jrv230017r54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.v142.3","article-title":"When and how to use lithium.","volume":"142","author":"Barroilhet","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"jrv230017r55","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamapsychiatry.2016.0432","article-title":"Self-harm, unintentional injury, and suicide in bipolar disorder during maintenance mood stabilizer treatment: a UK population-based electronic health records study.","volume":"73","author":"Hayes","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"jrv230017r56","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/acps.v141.6","article-title":"Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses.","volume":"141","author":"Velosa","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"jrv230017r57","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jamapsychiatry.2022.0337","article-title":"Association of lithium treatment with the risk of osteoporosis in patients with bipolar disorder.","volume":"79","author":"K\u00f6hler-Forsberg","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"April","key":"jrv230017r58","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neubiorev.2021.03.034","article-title":"Risk of cancer in bipolar disorder and the potential role of lithium: international collaborative systematic review and meta-analyses.","volume":"126","author":"Anmella","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"jrv230017r59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina57050433","article-title":"Efficacy of carbamazepine and its derivatives in the treatment of bipolar disorder.","volume":"57","author":"Grunze","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"jrv230017r60","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1192\/bjp.2019.137","article-title":"Sodium valproate in psychiatric practice: time for a change in perception.","volume":"215","author":"Owens","year":"2019","journal-title":"Br J Psychiatry"},{"issue":"4","key":"jrv230017r61","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.3892\/etm.2016.3628","article-title":"Neurological teratogenic effects of antiepileptic drugs during pregnancy.","volume":"12","author":"Nie","year":"2016","journal-title":"Exp Ther Med"},{"issue":"3","key":"jrv230017r62","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10072-021-05542-2","article-title":"Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?","volume":"43","author":"Mari","year":"2022","journal-title":"Neurol Sci"},{"key":"jrv230017r63","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211045870","article-title":"Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review.","volume":"11","author":"Besag","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"jrv230017r64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/npr2.v39.3","article-title":"Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.","volume":"39","author":"Oya","year":"2019","journal-title":"Neuropsychopharmacol Rep"},{"issue":"2","key":"jrv230017r65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/acps.v147.2","article-title":"Degree of exposure to psychotropic medications and mortality in people with bipolar disorder.","volume":"147","author":"Lin","year":"2023","journal-title":"Acta Psychiatr Scand"},{"issue":"333","key":"jrv230017r66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jad.2023.04.030","article-title":"Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder: a nationwide cohort study.","volume":"333","author":"Lintunen","year":"2023","journal-title":"J Affect Disord"},{"issue":"5","key":"jrv230017r67","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40263-019-00629-z","article-title":"Long-acting injectable second-generation\/atypical antipsychotics for the management of bipolar disorder: a systematic review.","volume":"33","author":"Keramatian","year":"2019","journal-title":"CNS Drugs"},{"issue":"5","key":"jrv230017r68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1192\/bjp.bp.116.195321","article-title":"Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis.","volume":"210","author":"Chatterton","year":"2017","journal-title":"Br J Psychiatry"},{"issue":"6","key":"jrv230017r69","first-page":"571","article-title":"Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical tria.","volume":"194","author":"Colom","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"2","key":"jrv230017r70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/acps.2012.127.issue-2","article-title":"Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder.","volume":"127","author":"de Barros Pellegrinelli","year":"2013","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"jrv230017r71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176849","article-title":"Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials.","volume":"12","author":"Chiang","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"jrv230017r72","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0006-3223(00)00931-8","article-title":"Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy.","volume":"48","author":"Miklowitz","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"3","key":"jrv230017r73","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1176\/appi.psychotherapy.20190035","article-title":"Clinical effectiveness trial of adjunctive interpersonal and social rhythm therapy for patients with bipolar disorder.","volume":"73","author":"Crowe","year":"2020","journal-title":"Am J Psychother"},{"issue":"7","key":"jrv230017r74","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/chi.0b013e31805c1613","article-title":"Dialectical behavior therapy for adolescents with bipolar disorder: a 1-year open trial.","volume":"46","author":"Goldstein","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"jrv230017r75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bdi.2019.21.issue-1","article-title":"A randomized controlled trial of MoodSwings 2.0: an internet-based self-management program for bipolar disorder.","volume":"21","author":"Gliddon","year":"2019","journal-title":"Bipolar Disord"},{"key":"jrv230017r76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jad.2018.06.017","article-title":"Mindfulness-based cognitive therapy for bipolar disorder: a systematic review.","volume":"240","author":"Lovas","year":"2018","journal-title":"J Affect Disord"},{"issue":"5","key":"jrv230017r77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bdi.2016.18.issue-5","article-title":"Is age of onset associated with severity, prognosis, and clinical features in bipolar disorder? a meta-analytic review.","volume":"18","author":"Joslyn","year":"2016","journal-title":"Bipolar Disord"},{"key":"jrv230017r78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jad.2015.04.024","article-title":"Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study.","volume":"182","author":"Altamura","year":"2015","journal-title":"J Affect Disord"},{"issue":"5","key":"jrv230017r79","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bdi.2009.11.issue-5","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord"},{"issue":"6","key":"jrv230017r80","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder.","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"jrv230017r81","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"jrv230017r82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S1461145703003341","article-title":"Long-term symptomatic status of bipolar I vs. bipolar II disorders.","volume":"6","author":"Judd","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"jrv230017r8","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision","author":"American Psychiatric Association","year":"2022"},{"key":"jrv230017r4","unstructured":"National Institute of Mental Health. Bipolar disorder. Accessed August 5, 2023. https:\/\/www.nimh.nih.gov\/health\/statistics\/bipolar-disorder"},{"key":"jrv230017r28","unstructured":"National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. 2016;(February). https:\/\/www.nice.org.uk\/guidance\/cg185"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2810502\/jama_nierenberg_2023_rv_230017_1696345483.35715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:02:36Z","timestamp":1696935756000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2810502"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":82,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.18588","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,10]]}}}